Home Cart 0 Sign in  
X

[ CAS No. 10075-50-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 10075-50-0
Chemical Structure| 10075-50-0
Chemical Structure| 10075-50-0
Structure of 10075-50-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10075-50-0 ]

Related Doc. of [ 10075-50-0 ]

Alternatived Products of [ 10075-50-0 ]

Product Details of [ 10075-50-0 ]

CAS No. :10075-50-0 MDL No. :MFCD00005670
Formula : C8H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :VXWVFZFZYXOBTA-UHFFFAOYSA-N
M.W : 196.04 Pubchem ID :24905
Synonyms :

Calculated chemistry of [ 10075-50-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.0
TPSA : 15.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.03 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.85
Log Po/w (XLOGP3) : 2.07
Log Po/w (WLOGP) : 2.93
Log Po/w (MLOGP) : 2.31
Log Po/w (SILICOS-IT) : 3.25
Consensus Log Po/w : 2.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.03
Solubility : 0.185 mg/ml ; 0.000943 mol/l
Class : Soluble
Log S (Ali) : -2.03
Solubility : 1.83 mg/ml ; 0.00931 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.14
Solubility : 0.0142 mg/ml ; 0.0000726 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.25

Safety of [ 10075-50-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10075-50-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10075-50-0 ]
  • Downstream synthetic route of [ 10075-50-0 ]

[ 10075-50-0 ] Synthesis Path-Upstream   1~72

  • 1
  • [ 10075-50-0 ]
  • [ 5192-03-0 ]
YieldReaction ConditionsOperation in experiment
82% With ammonium hydroxide; copper(I) iodide; 1-ethylacetoacetate-3-methyl imidazolium hydroxide In acetonitrile at 80℃; for 12 h; Inert atmosphere General procedure: An oven-dried flask was charged with aryl halide (1.0 mmol), aqueous NH3 (28percent, 1.5 mmol), CuI nanoparticles (0.02 mmol), 4a (3.0 mmol) and acetonitrile (2 mL). The contents were stirred under argon atmosphere at rt for 12 h. After completion of the reaction as monitored by TLC, the product was extracted with diethyl ether (5×5 mL). The organic layer was washed with brine, dried over MgSO4 and concentrated in vacuo. Purification was done on silica gel column, and elution with ethyl acetate–hexane mixture afforded the aminated products. All products obtained herein are known compounds, and were confirmed by 1H NMR, 13C NMR and mass spectroscopic analysis, see Supplementary data for full details.
Reference: [1] Tetrahedron, 2013, vol. 69, # 25, p. 5092 - 5097
  • 2
  • [ 10075-50-0 ]
  • [ 16066-91-4 ]
YieldReaction ConditionsOperation in experiment
98% With trans-N,N'-dimethyl-1,2-cyclohexyldiamine; sodium iodide In 1,4-dioxane at 110℃; for 22 - 23 h; A Schlenk tube was charged with CuI (9.6 mg, 0.0504 mmol, 5.0 molpercent), aryl bromide (if it is a solid; 1.00 mmol), NaI (300 mg, 2.00 mmol), briefly evacuated and backfilled with argon. [TRANS-N, NAPOS;-DIMETHYL-1,] 2-cyclohexanediamine [(16GEL,] 0. [10 MMOL,] 10 molpercent), aryl bromide (if it is a liquid; 1.00 mmol), and dioxane (1.0 mL) were added under argon. The Schlenk tube was sealed with a Teflon valve and the reaction mixture was stirred at [110 °C] for 22-23 h. The resulting suspension was allowed to reach room temperature, diluted with 30percent aq ammonia (5 [ML),] poured into water (20 mL), and extracted with dichloromethane [(3X15] mL). The combined organic phases were dried [(MGS04] or [NA2S04),] concentrated, and the residue was purified by flash chromatography on silica gel to provide the desired product.
82% With copper(I) oxide; <i>L</i>-proline; potassium iodide In ethanol at 110℃; for 30 h; Schlenk technique; Inert atmosphere; Sealed tube General procedure: A Schlenk tube was charged with Cu2O (7.2 mg, 10 molpercent), l-proline (11.5 mg, 20 molpercent), aryl (or heteroaryl) bromide (1 or 3,0.50 mmol), potassium iodide (KI) (249 mg, 0.75 mmol), and EtOH(1.5 mL) under nitrogen atmosphere. The Schlenk tube was sealedwith a teflon valve, and then the reaction mixture was stirred at110C for a period (the reaction progress was monitored by GCanalysis). After the reaction was completed, GC yield of high volatileproduct was determined using an appropriate internal standard(chlorobenzene or 1-chloro-4-methylbenzene) or the solvent wasremoved under reduced pressure. The residue obtained was puri-fied via silica gel chromatography (eluent: petroleum ether/ethylacetate = 10/1) to afford aryl iodides 2a–2o or heteroaryl iodides4a–4g.
Reference: [1] Journal of the American Chemical Society, 2002, vol. 124, # 50, p. 14844 - 14845
[2] Patent: WO2004/13094, 2004, A2, . Location in patent: Page 42-43
[3] Angewandte Chemie - International Edition, 2015, vol. 54, # 1, p. 263 - 266[4] Angew. Chem., 2015, vol. 127, # 01, p. 265 - 268,4
[5] Catalysis Today, 2016, vol. 274, p. 129 - 132
[6] Chemical Communications, 2012, vol. 48, # 33, p. 3993 - 3995
[7] Journal of the American Chemical Society, 2015, vol. 137, # 26, p. 8328 - 8331
[8] Synlett, 2001, # 2, p. 266 - 268
  • 3
  • [ 10075-50-0 ]
  • [ 74-83-9 ]
  • [ 1075-34-9 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 35, p. 11299 - 11305
  • 4
  • [ 10075-50-0 ]
  • [ 53330-94-2 ]
Reference: [1] ChemMedChem, 2012, vol. 7, # 12, p. 2179 - 2193
[2] ACS Combinatorial Science, 2017, vol. 19, # 6, p. 407 - 413
  • 5
  • [ 10075-50-0 ]
  • [ 127-19-5 ]
  • [ 53330-94-2 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 6, p. 1169 - 1175
  • 6
  • [ 10075-50-0 ]
  • [ 74-88-4 ]
  • [ 10075-52-2 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h;
Stage #2: at 20℃; for 0.166667 h;
2. To solution of 5-bromo-lH-indole (2.08 g, 10.6 mmol) in 35 mL of DMF, was added sodium hydride (60 wtpercent dispersion, 467 mg, 11.67 mmol) at 0 °C. After 30 min, iodomethane(663 μL·, 10.6 mmol) was added. The reaction mixture was allowed warm to RT, and stirred atRT for 10 min. The reaction was quenched with water at 0 °C, and extracted with EtOAc (x3).The combined organic extracts were dried (MgS04), filtered, and concentrated. Flash chromatography (10 percent EtOAc/Hexanes) gave 5-bromo-l-methyl-lH-indole (2.16 g, 97percent).JHNMR (400 MHz, CDC13) δ ppm: 7.74 (d, J=1.6 Hz, IH), 7.30 (dd, J=8.4, 2.0 Hz, IH), 7.19 (d,J=8.8 Hz, IH), 7.05 (d, J=3.2 Hz IH), 6.42 (d, J=2.8 Hz, IH), 3.78 (s, 3H).
96%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃;
General procedure: Indoles were methylated by a similar procedure to that reported in the literature.26 To a stirred suspension of NaH (60percent dispersion inmineral oil; 480 mg, 12.0 mmol) in DMF (10 mL) was added dropwise a solution of an indole (10.0 mmol) in DMF (10 mL) at 0 °C, and the mixture was stirred at room temperature for 30 min. To the mixture was added dropwise iodomethane (d 2.28; 934 mL, 15.0 mmol) at 0 °C, and the resulting mixture was stirred at room temperature overnight. The reaction was quenched with water and the aqueous layer was extracted with ethyl acetate. The combined organic layer was dried over MgSO4 and evaporated to leave a residue, which was purified by column chromatography using the indicated eluent.
95%
Stage #1: With potassium hydroxide In dimethyl sulfoxide for 1 h; Cooling with ice
Stage #2: at 20℃; for 0.75 h;
Potassium hydroxide (5.74 g, 102 mmol) was dissolved in dimethylsulfoxide (85 mL) and cooled in an ice bath. 5-Bromoindole (5.00 g, 26 mmol) was added portionwise and the reaction mixture stirred for 1 h before the dropwise addition of iodomethane (7.22 g, 51 mmol). After 45 min the solution was diluted with water (85 mL). The aqueous layer was extracted with diethyl ether (3 x 50 mL). The organic layer was then washed with water (2 x 50 mL), brine (2 x 50 mL) and dried (MgSO4). The solvent was removed under reduced pressure to afford a yellow oil that was purified using column chromatography eluting with light petroleum/ethyl acetate (10:1). Yellow solid (5.20 g, 95percent). 1H NMR (400MHz, CDCl3) δ 7.74 (t, 1 H, J = 2 Hz), 7.30-7.17 (m, 2 H), 7.04 (d, 1 H, J = 3 Hz), 6.41 (dd, J = 1 & 3 Hz), 3.76 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 135.4, 130.1, 130.0, 124.3, 123.3, 112.7, 110.7, 100.5, 33.0.
95.29%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 0 - 20℃; for 0.75 h;
To a stirred slurry solution of NaH (1.54 g, 1.2 eq) in THE (10 mL) at 0CC, 5-bromo- 1H-indole (5.0 g, 1.0 eq) in THE (10 mL) was added drop wise and stirred for about15 mm. Then, 0H31 (2.4 ml, 1.2 eq) was added drop wise and the resulting mixture was stirred at same temperature for about 15 mm, slowly raising the temperature of the mixture to room temperature. The mixture is continued to be stirred for another 30 mm. The reaction mixture was quenched with ice water and extracted with ethyl acetate, the combined organic layer and washed with 1 N HCI solution and water,dried and concentrated to yield the title product (5.1 g, 95.29percent) as a brownish oily mass.
91.5%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 1 h;
To a solution of compound 5-1 (5 g, 25.5 mmol) in dry DMF (100 mL) was added sodium hydride (NaH) (1.53 g, 38.26 mmol) under nitrogen atmosphere in an ice bath (0° C.), and then the reaction solution was warmed to r.t. and was reacted for 0.5 h. To this solution, all MeI (7.24 g, 38.26 mmol) was added at once and then the resulting solution was reacted at r.t. for 1 h. The reaction was monitored by TLC until the completion of reaction. Then saturated NH4Cl (aq.) was added to the solution to quench the reaction. The reaction solution was extracted with EtOAc (100 mL) twice, and the organic phase was washed with saturated brine (50 mL×2), dried over anhydrous Na2SO4, filtered and concentrated to remove solvent, therefore obtaining compound 5-2 (4.9 g, Yield 91.5percent). 1HNMR (400 MHz, CDCl3): δ ppm 7.74-7.75 (m, 1H), 7.28-7.31 (m, 1H), 7.18-7.21 (m, 1H), 7.04-7.06 (m, 1H), 6.41-6.43 (m, 1H), 3.78 (s, 3H)
77%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 5 h; Inert atmosphere
In a dry flask under argon, 5-bromoindole (ab) (1.5 g, 7.65 mmol) was dissolved in dry DMF (15 mL). After cooling this mixture to 0 °C, sodium hydride (367 mg, 9.18 mmol, 60percent in oil) was added to form the anion. This solution was stirred at 0 °C for 30 minutes. Then, methyl iodide (0.525 mL, 1.196 g, 8.42 mmol) was added. The resulting mixture was then stirred at room temperature for 5 hours and quenched with water. After dilution in ethyl acetate and separation, the organic layer was washed with brine three times, dried over anhydrous MgSO4 and concentrated. The desired product (ia) (1.24 g, 5.9 mmol) was obtained as a yellow solid. Yield: 77percent. 1H NMR (300 MHz, CDCl3): δ = 3.79 (s, 3H, CH3), 6.42 (d, J = 3.3 Hz, 1H, CH), 7.03 (d, J = 3.3 Hz, 1H, CH), 7.18 (d, J= 8.7 Hz, 1H, CH), 7.25-7.31 (m, 1H, CH), 7.74 (d, J= 1.8 Hz, 1H, CH) ppm.
77%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h; Inert atmosphere
Stage #2: at 20℃; for 5 h; Inert atmosphere
DMF (15 mL). After cooling this mixture to 0 °C, sodium hydride (367 mg, 9.18 mmol, 60percent in oil) was added to form the anion. This solution was stirred at 0 °C for 30 minutes. Then, methyl iodide (0.525 mL, 1.196 g, 8.42 mmol) was added. The resulting mixture was then stirred at room temperature for 5 hours and quenched with water. After dilution in ethyl acetate and separation, the organic layer was washed with brine three times, dried over anhydrous MgS04 and concentrated. The desired product (ia) (1.24 g, 5.9 mmol) was obtained as a yellow solid. Yield: 77percent.1H NMR (300 MHz, CDC13): δ = 3.79 (s, 3H, CH3), 6.42 (d, J= 3.3 Hz, 1H, CH), 7.03 (d, J= 3.3 Hz, 1H, CH), 7.18 (d, J = 8.7 Hz, 1H, CH), 7.25-7.31 (m, 1H, CH), 7.74 (d, J = 1.8 Hz, 1H, CH) ppm.

Reference: [1] Chemistry Letters, 1991, # 7, p. 1125 - 1128
[2] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 3, p. 333 - 336
[3] Organic Letters, 2015, vol. 17, # 2, p. 254 - 257
[4] Patent: WO2016/114816, 2016, A1, . Location in patent: Paragraph 0332
[5] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 12, p. 4524 - 4529
[6] Tetrahedron, 2016, vol. 72, # 5, p. 734 - 745
[7] Tetrahedron Letters, 2013, vol. 54, # 8, p. 843 - 846
[8] Patent: WO2014/202580, 2014, A1, . Location in patent: Page/Page column 94
[9] MedChemComm, 2018, vol. 9, # 2, p. 275 - 281
[10] Journal of Organic Chemistry, 2011, vol. 76, # 3, p. 749 - 759
[11] Patent: WO2006/2981, 2006, A1, . Location in patent: Page/Page column 96-97
[12] Journal of Medicinal Chemistry, 2012, vol. 55, # 22, p. 9467 - 9491
[13] Patent: US2017/313683, 2017, A1, . Location in patent: Paragraph 0289-0290
[14] Organometallics, 2017, vol. 36, # 4, p. 767 - 776
[15] Chemistry - A European Journal, 2016, vol. 22, # 13, p. 4400 - 4404
[16] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 11, p. 5952 - 5961
[17] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 2813 - 2827
[18] Journal of the American Chemical Society, 2011, vol. 133, # 10, p. 3312 - 3315
[19] Patent: EP2548864, 2013, A1, . Location in patent: Paragraph 0319; 0320
[20] Patent: WO2013/14102, 2013, A1, . Location in patent: Page/Page column 64; 65
[21] Helvetica Chimica Acta, 2006, vol. 89, # 5, p. 936 - 946
[22] Organic Letters, 2013, vol. 15, # 1, p. 112 - 115
[23] Organic Letters, 2013, vol. 15, # 24, p. 6190 - 6193
[24] European Journal of Medicinal Chemistry, 1990, vol. 25, # 2, p. 191 - 196
[25] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 8, p. 2342 - 2346
[26] Journal of the American Chemical Society, 2007, vol. 129, # 26, p. 8328 - 8332
[27] Patent: US2007/112011, 2007, A1,
[28] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 22, p. 6134 - 6137
[29] Patent: WO2008/77138, 2008, A1, . Location in patent: Page/Page column 65
[30] Journal of Medicinal Chemistry, 2009, vol. 52, # 7, p. 1853 - 1863
[31] Organic Letters, 2010, vol. 12, # 21, p. 4956 - 4959
[32] European Journal of Medicinal Chemistry, 2010, vol. 45, # 2, p. 588 - 597
[33] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 17, p. 6422 - 6431
[34] Chemical Communications, 2011, vol. 47, # 46, p. 12553 - 12555
[35] Patent: WO2011/103546, 2011, A1, . Location in patent: Page/Page column 66
[36] Organic Letters, 2012, vol. 14, # 16, p. 4130 - 4133
[37] Chemical Communications, 2012, vol. 48, # 89, p. 11023 - 11025
[38] Chemical Communications, 2014, vol. 50, # 81, p. 12181 - 12184
[39] Journal of Medicinal Chemistry, 2013, vol. 56, # 17, p. 7060 - 7072
[40] Current Medicinal Chemistry, 2014, vol. 21, # 14, p. 1654 - 1666
[41] Journal of the American Chemical Society, 2014, vol. 136, # 29, p. 10266 - 10269
[42] Marine Drugs, 2015, vol. 13, # 1, p. 460 - 492
[43] Patent: WO2016/180537, 2016, A1, . Location in patent: Page/Page column 132
[44] Angewandte Chemie - International Edition, 2016, vol. 55, # 40, p. 12219 - 12223[45] Angew. Chem., 2016, vol. 128, p. 12407 - 12411,5
[46] Marine Drugs, 2016, vol. 14, # 12,
[47] Chemical Communications, 2017, vol. 53, # 33, p. 4593 - 4596
[48] Organic and Biomolecular Chemistry, 2017, vol. 15, # 28, p. 5904 - 5907
[49] Chemical Communications, 2017, vol. 53, # 92, p. 12422 - 12425
[50] Organic Letters, 2018, vol. 20, # 16, p. 4898 - 4901
  • 7
  • [ 10075-50-0 ]
  • [ 616-38-6 ]
  • [ 10075-52-2 ]
YieldReaction ConditionsOperation in experiment
99% With 1,4-diaza-bicyclo[2.2.2]octane In DMF (N,N-dimethyl-formamide) at 90 - 95℃; for 5 h; To a solution of 5-bromoindole (1.0 g, 5.10 mmol) in DMC (10 ML), DABCO (0.057 g, 0.51 mmol) is added followed by DMF (1 ML).The resulting solution is heated to 90-95° C. for 5 h.The reaction is cooled to RT, and diluted with ethyl acetate (EtOAc, 50 ML) and H2O (50 ML).The organic layer is separated and washed in sequence with H2O (50 ML), 10percent aqueous citric acid (2*50 ML) and H2O (4*50 ML).The organic layer is dried over anhydrous sodium sulfate (Na2SO4), filtered and concentrated under vacuum to give 5-bromo-1-methylindole (about 1.06 g, 99percent) as a golden colored solid: 1H NMR (CDCl3) δ 7.72 (d, 1H), 7.26 (dd, 1H), 7.13 (d, 1H), 7.00 (d, 1H), 6.39 (d, 1H), 3.71 (s, 3H); 13C NMR (CDCl3) δ 135.3, 130.1, 129.9, 124.2, 123.2, 112.6, 110.6, 100.5, 32.9; MS m/z 209 [M+1]+.
Reference: [1] Patent: US2004/59131, 2004, A1, . Location in patent: Page 5
[2] Organic Process Research and Development, 2001, vol. 5, # 6, p. 604 - 608
[3] RSC Advances, 2014, vol. 4, # 91, p. 50271 - 50276
[4] Synthetic Communications, 2012, vol. 42, # 1, p. 128 - 135
[5] Patent: US6326501, 2001, B1,
[6] Asian Journal of Chemistry, 2018, vol. 30, # 6, p. 1201 - 1204
[7] Chemical Papers, 2018, vol. 72, # 6, p. 1369 - 1378
  • 8
  • [ 10075-50-0 ]
  • [ 74-83-9 ]
  • [ 10075-52-2 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 1 h;
General procedure: Sodium hydride (60percent in mineral oil, 1.10 equiv) was suspended in DMF [0.6 M]. 1H-Indole (1.00 equiv)was solubilized in DMF [1.0 M] and added to the suspension at 0 °C. The mixture was stirred at rt for 30min. Bromoalkyl or TMSCl (1.50 equiv) was diluted in DMF [3.0 M] and added to the solution at 0 °C.The mixture was stirred at rt for 1 hour. The solution was quenched with water (20 mL) and extractedthree times with EtOAc (10 mL). The organic layers were combined, dried over MgSO4 and concentratedunder reduced pressure. The liquid was filtered through a 5 cm pad of silica with 100percent pentane or Et2O toafforded the title compound.
81%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.166667 h;
Stage #2: at 0 - 20℃; for 2 h;
General procedure: NaH (6.1 mmol, 1.2 equiv) was slowly added to a solution of 5-bromoindole/indazole (5.1 mmol,1 equiv) in DMF (10 mL) at 0 °C. The mixture was stirred at 0 °C for 10 min then the alkylhalide (6.1 mmol, 1.2 equiv) was added at the same temperature. The reaction mixture wascontinued to stir at rt for 2 h. When the reaction was complete [TLC (EtOAc/hexane 1:5)], themixture was extracted with EtOAc (2 × 20 mL) and washed with water (2 × 20 mL). The organiclayer was separated, dried over anhydrous Na2SO4 and the solvent removed under reducedpressure. The residue obtained was purified by flash column chromatography [silica gel (230–400 mesh; Merck), EtOAc/hexane 1:5].
Reference: [1] Organic Letters, 2018, vol. 20, # 5, p. 1473 - 1476
[2] Beilstein Journal of Organic Chemistry, 2018, vol. 14, p. 1208 - 1214
[3] Beilstein Journal of Organic Chemistry, 2016, vol. 12, p. 2893 - 2897
  • 9
  • [ 10075-50-0 ]
  • [ 10075-52-2 ]
Reference: [1] Patent: US5252732, 1993, A,
[2] Patent: US5310901, 1994, A,
[3] Chemical Communications, 2013, vol. 49, # 23, p. 2368 - 2370
[4] Patent: US5349061, 1994, A,
[5] Patent: US2010/144726, 2010, A1,
  • 10
  • [ 10075-50-0 ]
  • [ 80-48-8 ]
  • [ 10075-52-2 ]
Reference: [1] Patent: US6017945, 2000, A,
  • 11
  • [ 10075-50-0 ]
  • [ 616-38-6 ]
  • [ 10075-52-2 ]
Reference: [1] Journal of Organic Chemistry, 2003, vol. 68, # 5, p. 1954 - 1957
  • 12
  • [ 10075-50-0 ]
  • [ 22190-33-6 ]
YieldReaction ConditionsOperation in experiment
71% at 10 - 20℃; for 3.33333 h; Example 28Preparation of tert-butyl 5-vinylindoline-1-carboxylate (BI10) Step 1. 5-Bromo-indoline (BI11); To 5-Bromo-1H-indole (2.5 g, 12.82 mmol) in acetic acid (10.0 mL), NaCNBH3 (2.38 g, 38.46 mmol) was added portion wise at 10° C. over the period of 20 min After that the reaction mixture was stirred at RT for 3 h. The reaction mixture was diluted with water and extracted with diethyl ether. The organic layer was washed with saturated NaHCO3, water and brine solution. The combined ether layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford title compound as a pale yellow semi-solid (1.8 g, 71percent).
71% at 10 - 20℃; for 3.33333 h; To 5-Bromo-1H-indole (2.5 g, 12.82 mmol) in acetic acid (10.0 mL), NaCNBH3 (2.38 g, 38.46 mmol) was added portion wise at 10° C. over the period of 20 min. After that the reaction mixture was stirred at ambient temperature for 3 h. The reaction mixture was diluted with water and extracted with diethyl ether. The organic layer was washed with saturated NaHCO3, water and brine solution. The combined ether layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford title compound as a pale yellow semi-solid (1.8 g, 71percent).
71% at 10 - 20℃; for 3.33333 h; To 5-Bromo-1H-indole (2.5 g, 12.82 mmol) in acetic acid (10.0 mL), NaCNBIL (2.38 g, 38.46 mmol) was added portion wise at 10 °C over the period of 20 min. After that the reaction mixture was stirred at RT for 3 h. The reaction mixture was diluted with water and extracted with diethyl ether. The organic layer was washed with saturated NaHCC>3, water and brine solution. The combined ether layer was dried over anhydrous Na2S04 and concentrated under reduced pressure to afford title compound as a pale yellow semi-solid (1.8 g, 71percent).
71% at 10 - 20℃; for 3 h; To 5-Bromo-1H-indole (2.5 g, 12.82 mmol) in acetic acid (10.0 mL), NaCNBH3 (2.38 g, 38.46 mmol) was added portion wise at 10° C. over the period of 20 min.
After that the reaction mixture was stirred at RT for 3 h.
The reaction mixture was diluted with water and extracted with diethyl ether.
The organic layer was washed with saturated NaHCO3, water and brine solution.
The combined ether layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford title compound as a pale yellow semi-solid (1.8 g, 71percent).
71% at 10 - 20℃; for 3.33333 h; Example 28 Preparation of tert-Butyl 5-vinylindoline-1-carboxylate (BI10) Step 1. 5-Bromo-indoline (BI11) To 5-Bromo-1H-indole (2.5 g, 12.82 mmol) in acetic acid (10.0 mL), NaCNBH3 (2.38 g, 38.46 mmol) was added portion wise at 10° C. over the period of 20 min. After that the reaction mixture was stirred at ambient temperature for 3 h. The reaction mixture was diluted with water and extracted with diethyl ether. The organic layer was washed with saturated NaHCO3, water and brine solution. The combined ether layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford title compound as a pale yellow semi-solid (1.8 g, 71percent).
38% at 0 - 20℃; for 16 h; 10 mL of acetic acid was added to 5-bromoindole (2.5 g, 12.8 mmol) and cooled to 0°C. Sodium triacetoxyborohydride(2.38 g, 37.9 mmol) was added thereto, and the mixture was stirred at room temperature for 16 hours. Afteraddition of water, the reaction solution was extracted with Et2O, and the organic layer washed with sodium bicarbonateaqueous solution. The organic layer was dried with MgSO4 and purified by column chromatography to obtain the titlecompound (0.95 g, 38 percent).1H-NMR (CDCl3) δ 7.19 (1H, d), 7.09 (1H, dd), 6.50 (1H, d), 3.74 (1H, brs), 3.56 (2H, t), 3.02 (2H, t)

Reference: [1] Organic Letters, 2013, vol. 15, # 11, p. 2798 - 2801
[2] Chemical Papers, 2016, vol. 70, # 5, p. 635 - 648
[3] Tetrahedron Letters, 2005, vol. 46, # 12, p. 2071 - 2074
[4] Nucleosides, Nucleotides and Nucleic Acids, 2005, vol. 24, # 8, p. 1147 - 1165
[5] Chemical Communications, 2017, vol. 53, # 66, p. 9262 - 9264
[6] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2462 - 2471
[7] Patent: US2012/329649, 2012, A1, . Location in patent: Page/Page column 46
[8] Patent: WO2014/100163, 2014, A1, . Location in patent: Page/Page column 85
[9] Patent: US2014/171308, 2014, A1, . Location in patent: Paragraph 0412
[10] Patent: WO2014/100206, 2014, A1, . Location in patent: Page/Page column 86
[11] Patent: US2014/171312, 2014, A1, . Location in patent: Paragraph 0577; 0578
[12] Patent: US9211280, 2015, B2, . Location in patent: Page/Page column 85-86
[13] Angewandte Chemie - International Edition, 2016, vol. 55, # 40, p. 12219 - 12223[14] Angew. Chem., 2016, vol. 128, p. 12407 - 12411,5
[15] Patent: EP3239143, 2017, A2, . Location in patent: Paragraph 0288
[16] Patent: WO2005/123748, 2005, A1, . Location in patent: Page/Page column 70
[17] Patent: WO2013/166015, 2013, A1, . Location in patent: Paragraph 0202; 0203
[18] Patent: WO2013/166013, 2013, A1, . Location in patent: Paragraph 0122; 0123; 0124
[19] Organic Letters, 2013, vol. 15, # 22, p. 5662 - 5665
[20] Patent: US2014/171314, 2014, A1, . Location in patent: Page/Page column
[21] RSC Advances, 2015, vol. 5, # 30, p. 23727 - 23736
[22] Chemistry - A European Journal, 2015, vol. 21, # 14, p. 5370 - 5379
[23] Journal of Organic Chemistry, 2016, vol. 81, # 2, p. 396 - 403
[24] Chemical Communications, 2017, vol. 53, # 82, p. 11368 - 11371
[25] Journal of Organic Chemistry, 2018, vol. 83, # 4, p. 2425 - 2437
[26] Organic and Biomolecular Chemistry, 2018, vol. 16, # 32, p. 5889 - 5898
[27] Chemical Communications, 2018, vol. 54, # 20, p. 2494 - 2497
  • 13
  • [ 10075-50-0 ]
  • [ 124-38-9 ]
  • [ 1670-81-1 ]
YieldReaction ConditionsOperation in experiment
65%
Stage #1: With isopropylmagnesium chloride In tetrahydrofuran at 0℃; for 0.166667 h;
Stage #2: With n-butyllithium In tetrahydrofuran; hexane at -20℃; for 0.5 h;
Stage #3: at -20℃; for 0.5 h;
To a solution of 5-Bromo-1H-indole (0.86 g, 4.4 mmol, 1.0 equiv.) in dryTHF (20 mL) at 0 C was added a 2 M solution of i-PrMgCl in THF (2.2 mL, 4.4 mmol, 1 equiv.) during5 min. The clear solution was stirred at that temperature for an additional 5 min, and a 2.5Msolution ofn-BuLi in hexanes (3.5 mL, 8.8 mmol, 2.0 equiv.) was added dropwise during 5 min, while maintainingthe temperature below 20 C. The resulting mixture was stirred at that temperature for 0.5 h, dry CO2(0.2 g, 4.4 mmol, 1.0 equiv.) was added to 20 C. The resulting mixture was warmed to 20 C in0.5 h and quenched with water (6 mL). After stirring the mixture below for 10 min, the phases wereseparated and the water phase was extracted one additional time with ethyl acetate. The resultingsuspension was allowed to reach room temperature and fitered through a 0.5 1 cm pad of silicagel eluted with 10 mL of ethyl acetate. The ®ltrate was concentrated and the residue was puri®ed byflash chromatography on silica gel (eluent: petroleum ether/ethyl acetate = 3:1) to afford product 3das off-white solid, 0.46 g (yield: 65percent), m.p.: 210–214 C. 1H-NMR (600 MHz, DMSO) 12.39 (s, 1H),11.46 (s, 1H), 8.25 (s, 1H), 7.72 (dd, J = 8.5, 1.5 Hz, 1H), 7.45 (dd, J = 8.4, 5.7 Hz, 2H), 6.57 (s, 1H).13C-NMR (151 MHz, DMSO) 168.90, 138.80, 127.64, 127.35, 123.28, 122.67, 121.87, 111.57, 102.93.
Reference: [1] Molecules, 2017, vol. 22, # 11,
[2] Journal of the American Chemical Society, 2017, vol. 139, # 28, p. 9467 - 9470
  • 14
  • [ 10075-50-0 ]
  • [ 2258-42-6 ]
  • [ 1670-81-1 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 5, p. 658 - 666
  • 15
  • [ 10075-50-0 ]
  • [ 1670-81-1 ]
Reference: [1] Chinese Chemical Letters, 2010, vol. 21, # 12, p. 1407 - 1410
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2692 - 2703
  • 16
  • [ 10075-50-0 ]
  • [ 4692-98-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 43, p. 7455 - 7457
  • 17
  • [ 10075-50-0 ]
  • [ 1189-71-5 ]
  • [ 90271-86-6 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: at 0℃; for 2 h;
Stage #2: With N,N-dimethyl-formamide In acetonitrile at 0℃; for 2 h;
General procedure: To a solution of the appropriate indoles 3a–d (6.8 mmol) in anhydrous acetonitrile (6.0 mL),chlorosulfonyl isocyanate (CSI) (0.63 mL, 7.25 mmol) was added dropwise at 0 °C and the reactionmixture was stirred at 0 °C for 2 h. Anhydrous dimethylformamide (DMF) (1.3 mL, 170.0 mmol)was added dropwise and the mixture was stirred at 0 C for 2 h. The mixture was poured intoice-water and the obtained precipitate was filtered off, dried (anhydrous Na2SO4) and purified bycolumn chromatography using petroleum ether/ethyl acetate (40/60) (for 4b–d) or ethyl acetate (for4a) as eluent.
Reference: [1] Marine Drugs, 2018, vol. 16, # 8,
  • 18
  • [ 10075-50-0 ]
  • [ 75-52-5 ]
  • [ 90271-86-6 ]
YieldReaction ConditionsOperation in experiment
42% at 90℃; for 36 h; General procedure: In the same manner as in Example 1 except that the reaction was carried out under the conditions shown in Tables 1 and 2, The compound (3105) was obtained in an isolated yield of 42percent.
Reference: [1] Advanced Synthesis and Catalysis, 2014, vol. 356, # 2-3, p. 347 - 352
[2] Patent: JP5754768, 2015, B2, . Location in patent: Paragraph 0077; 0078
  • 19
  • [ 10075-50-0 ]
  • [ 90271-86-6 ]
Reference: [1] Chinese Chemical Letters, 2012, vol. 23, # 8, p. 903 - 906
  • 20
  • [ 10075-50-0 ]
  • [ 110-18-9 ]
  • [ 90271-86-6 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 18, p. 2315 - 2317
  • 21
  • [ 10075-50-0 ]
  • [ 90271-86-6 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 25, p. 3334 - 3336
  • 22
  • [ 10075-50-0 ]
  • [ 90271-86-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2000, vol. 8, # 2, p. 363 - 371
  • 23
  • [ 10075-50-0 ]
  • [ 40432-84-6 ]
Reference: [1] Tetrahedron Letters, 1994, vol. 35, # 19, p. 3013 - 3016
[2] Organic and Biomolecular Chemistry, 2012, vol. 10, # 10, p. 2101 - 2112
[3] Journal of the American Chemical Society, 2012, vol. 134, # 26, p. 10815 - 10818
  • 24
  • [ 10075-50-0 ]
  • [ 1609-47-8 ]
  • [ 32996-16-0 ]
Reference: [1] Synthesis, 2004, # 4, p. 568 - 572
  • 25
  • [ 10075-50-0 ]
  • [ 124-38-9 ]
  • [ 10406-06-1 ]
YieldReaction ConditionsOperation in experiment
96% With lithium tert-butoxide In N,N-dimethyl-formamide at 100℃; for 24 h; General procedure: In a dried two-necked test tube was charged with LiOtBu (160 mg, 2.00 mmol) and indole 1a (23.4 mg, 0.4 mmol). The reaction vessel was evacuated under high vacuum and the atmosphere was replace with a balloon of CO2. Then DMF (2 mL) was added and the mixture was stirred for 24 h at 100°C. Then the result mixture was cooled and carefully quenched with a solution of HCl (2 N) and extracted with EtOAc (5x). The combined organic layers were washed with water (2x), brine (1x) and dry over MgSO4. The dried organics were concentrated under reduce pressure and the residue was purified by preparative TLC (hexane:acetone = 1:1) to afford the desired product 2a (153.0 mg, 95percent) as a white solid.
Reference: [1] Organic Letters, 2012, vol. 14, # 20, p. 5326 - 5329,4
[2] Heterocycles, 2015, vol. 90, # 2, p. 1196 - 1204
  • 26
  • [ 10075-50-0 ]
  • [ 10406-06-1 ]
Reference: [1] Patent: US2012/277205, 2012, A1,
[2] Patent: WO2012/146318, 2012, A1,
[3] Patent: EP2548864, 2013, A1,
[4] Patent: WO2013/14102, 2013, A1,
[5] Journal of Medicinal Chemistry, 2014, vol. 57, # 17, p. 7293 - 7316
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 7, p. 2745 - 2763
[7] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 3006 - 3016
[8] Chemical Papers, 2018, vol. 72, # 6, p. 1369 - 1378
  • 27
  • [ 10075-50-0 ]
  • [ 407-25-0 ]
  • [ 10406-06-1 ]
Reference: [1] Biochemistry, 2016, vol. 55, # 21, p. 3020 - 3035
  • 28
  • [ 10075-50-0 ]
  • [ 32774-29-1 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 10, p. 1231 - 1233
[2] Organic Letters, 2017, vol. 19, # 7, p. 1504 - 1507
  • 29
  • [ 67-56-1 ]
  • [ 10075-50-0 ]
  • [ 10075-48-6 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 19, p. 5228 - 5231
[2] RSC Advances, 2015, vol. 5, # 86, p. 70329 - 70332
  • 30
  • [ 10075-50-0 ]
  • [ 10075-48-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 3, p. 333 - 336
[2] Patent: WO2012/119046, 2012, A2,
[3] ChemMedChem, 2012, vol. 7, # 12, p. 2179 - 2193
[4] Angewandte Chemie - International Edition, 2013, vol. 52, # 11, p. 3250 - 3254[5] Angew. Chem., 2013, vol. 125, # 11, p. 3332 - 3336,5
[6] Chemistry - A European Journal, 2015, vol. 21, # 43, p. 15104 - 15107
  • 31
  • [ 10075-50-0 ]
  • [ 10075-49-7 ]
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 43, p. 15104 - 15107
  • 32
  • [ 10075-50-0 ]
  • [ 106698-07-1 ]
Reference: [1] Carbohydrate Research, 2015, vol. 402, p. 50 - 55
  • 33
  • [ 10075-50-0 ]
  • [ 68-12-2 ]
  • [ 1196-69-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 20, p. 5833 - 5836
[2] Journal of Organic Chemistry, 1986, vol. 51, # 26, p. 5106 - 5110
[3] Heterocycles, 1992, vol. 34, # 6, p. 1169 - 1175
[4] Patent: WO2016/114816, 2016, A1, . Location in patent: Paragraph 093
  • 34
  • [ 10075-50-0 ]
  • [ 594-19-4 ]
  • [ 1196-69-6 ]
Reference: [1] Patent: US6200978, 2001, B1,
  • 35
  • [ 10075-50-0 ]
  • [ 1196-69-6 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 16, p. 4086 - 4089
  • 36
  • [ 10075-50-0 ]
  • [ 142273-20-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 10, p. 2101 - 2112
  • 37
  • [ 10075-50-0 ]
  • [ 5419-55-6 ]
  • [ 144104-59-6 ]
YieldReaction ConditionsOperation in experiment
25%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h; Inert atmosphere
Stage #2: With n-butyllithium In tetrahydrofuran; hexane at 0℃; for 0.166667 h; Inert atmosphere
Stage #3: at 0 - 20℃; Inert atmosphere
A dry and nitrogen-flushed three-necked flask, equipped with a magnetic stirrer and a septum, was charged with NaH (1.02 g, 42.5 mmol) in dry THF (80 mL). The 5-bromoindole (5.0 g, 25.5 mmol) was added dropwise to the solution under an N2 atmosphere at 0 °C, and the reaction mixture was stirred for 15 min. After that the n-BuLi (2.5 M in hexane, 15 mL, 37.5 mmol) was slowly added to the reaction mixture, and then the mixture was stirred for 10 mins. Next the triisopropyl borate (22 mL, 51 mmol) was added dropwise to the mixture. When the addition was complete, the mixture was warmed to room temperature overnight and stirred for 2 hours. The reaction mixture was quenched with saturated NH4Cl and stirred for 30 min. The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic layer was washed with water and brine, and dried over Na2SO4. After completely removing the solvent, the residue was treated with EtOAc/petroleum ether and filtered to afford 1H-indol-5-ylboronic acid (b1) as colorless solid (1.02 g, 25percent yield). 2 1H-NMR (DMSO-d6) δ 11.1 (s, 1H), 8.30 (s, 1H), 7.81 (d, 1H, J=8.1 Hz), 7.47 (d, 1H, J=8.1 Hz), 7.34 (s, 1H).13C-NMR (100 MHz, (DMSO-d6) δ 138.0, 128.0, 127.5, 127.4, 127.3, 125.4, 111.0, 102.0.
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 1, p. 35 - 42
  • 38
  • [ 10075-50-0 ]
  • [ 144104-59-6 ]
Reference: [1] Patent: WO2006/51851, 2006, A1, . Location in patent: Page/Page column 71-72
[2] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
[3] Journal of Organic Chemistry, 2007, vol. 72, # 3, p. 1047 - 1050
[4] Organic Letters, 2012, vol. 14, # 18, p. 4814 - 4817,4
[5] Journal of Organic Chemistry, 2013, vol. 78, # 13, p. 6427 - 6439
  • 39
  • [ 10075-50-0 ]
  • [ 688-74-4 ]
  • [ 144104-59-6 ]
Reference: [1] Patent: US6307056, 2001, B1,
  • 40
  • [ 10075-50-0 ]
  • [ 5419-55-6 ]
  • [ 144104-59-6 ]
Reference: [1] Patent: EP1820799, 2007, A1,
  • 41
  • [ 10075-50-0 ]
  • [ 13675-18-8 ]
  • [ 144104-59-6 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 11, p. 1859 - 1863
  • 42
  • [ 10075-50-0 ]
  • [ 75-03-6 ]
  • [ 195253-49-7 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: With sodium hydride In DMF (N,N-dimethyl-formamide) at 80℃; for 0.5 h;
Stage #2: at 80℃; for 2 h;
Example 15 5-Bromo-3-(2,4-dichlorobenzoyl)-1-ethyl-1H-indole [0380] 1a) 5-Bromo-1-ethyl-1H-indole [0381] In 75 mL of anhydrous dimethylformamide, place 3.06 g (76.5 mmol) of sodium hydride in 60percent suspension in mineral oil. Stir and heat the mixture to 80° C. Add progressively, using a spatula, 5.0 g (25.5 mmol) of 5-bromo-1H-indole. Continue the heating for 30 minutes (until no further hydrogen is evolved). Cool the mixture to ambient temperature and add 4 mL (51 mmol) of iodoethane. Heat the mixture again to 80° C. for 2 hours. Hydrolyse the reaction medium. Extract with dichloromethane, dry the organic phase over anhydrous sodium sulfate and evaporate. Purify the evaporation residue by chromatography on silica gel with elution by dichloromethane (Int. 49). [0382] Yield: 89percent [0383] Yellow oil
Reference: [1] Archiv der Pharmazie, 1997, vol. 330, # 5, p. 141 - 145
[2] Patent: US2004/67998, 2004, A1, . Location in patent: Page/Page column 18
  • 43
  • [ 10075-50-0 ]
  • [ 74-96-4 ]
  • [ 195253-49-7 ]
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 1, p. 35 - 42
[2] MedChemComm, 2018, vol. 9, # 2, p. 275 - 281
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 11, p. 5952 - 5961
[4] European Journal of Medicinal Chemistry, 2010, vol. 45, # 2, p. 588 - 597
[5] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 17, p. 6422 - 6431
  • 44
  • [ 75-21-8 ]
  • [ 10075-50-0 ]
  • [ 148366-28-3 ]
Reference: [1] Patent: US5310901, 1994, A,
[2] Patent: US5352783, 1994, A,
[3] Patent: US5252732, 1993, A,
[4] Patent: US5349061, 1994, A,
  • 45
  • [ 10075-50-0 ]
  • [ 116-11-0 ]
  • [ 540-51-2 ]
  • [ 148366-28-3 ]
Reference: [1] Patent: US2002/65295, 2002, A1,
[2] Patent: US6569867, 2003, B2,
  • 46
  • [ 10075-50-0 ]
  • [ 107-07-3 ]
  • [ 148366-28-3 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 90, p. 10602 - 10604
  • 47
  • [ 10075-50-0 ]
  • [ 540-51-2 ]
  • [ 148366-28-3 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 19, p. 6721 - 6726
[2] Angewandte Chemie - International Edition, 2014, vol. 53, # 20, p. 5142 - 5146[3] Angew. Chem., 2014, vol. 126, # 20, p. 5237 - 5241,5
  • 48
  • [ 10075-50-0 ]
  • [ 148366-28-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 17, p. 2451 - 2454
[2] Patent: WO2014/202580, 2014, A1,
  • 49
  • [ 10075-50-0 ]
  • [ 24424-99-5 ]
  • [ 182344-70-3 ]
YieldReaction ConditionsOperation in experiment
100% at 20℃; for 3 h; A solution of 5-bromo-indole (5.0 g, 25.5 mmol), di-tert-butyl dicarbonate (7.6 mL, 33.1 mmol) and 4-dimethylaminopyridine (0.15 g, 1.23 mmol) in acetonitrile (50 mL) was stirred at room temperature for 3 hr.
An aqueous citric acid solution was added to the reaction solution, and the mixture was extracted with ethyl acetate.
The extract was washed with aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give the title compound (7.8 g, yield 100percent) as a pale-yellow oil.
99% With dmap In acetonitrile at 23℃; for 0.5 h; Example 12. Synthesis of N-Boc-5-bromoindole (SlO)99percent S10To 5-bromoindole (196 mg, 1.00 mmol, 1.00 equiv) in acetonitrile (2.0 niL) at 23 °C was added di-tert-buty\\ dicarbonate (276 rnL, 1.20 mmol, 1.20 equiv) and A- dimethylaminopyridine (12.0 mg, 0.100 mmol, 10.0 molpercent). After stirring for 30 min at 23 0C, the reaction mixture was concentrated in vacuo. The residue was purified by chromatography on silica gel eluting with hexanes/EtOAc 30:1 (v/v) to afford 293 mg of the title compound as a colorless solid (99percent yield).R/= 0.35 (hexanes/EtOAc 30:1 (v/v)). NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 0C, δ): 8.02 (d, / = 8.8 Hz, IH), 7.69 (d, / = 2.0 Hz, IH), 7.58 (d, / = 3.6 Hz, IH), 7.39 (dd, /= 8.8 Hz, 2.0 Hz, IH), 6.50 (d, / = 3.6 Hz, IH), 1.67 (s, 9H). 13C NMR (100 MHz, CDCl3, 23 0C, δ): 149.40, 133.90, 132.22, 127.00, 123.51, 116.54, 115.94, 106.45, 84.12, 28.14. (Note: Only ten peaks were observed probably due to accidental overlap of two peaks)
97% With dmap; triethylamine In dichloromethane at 20℃; for 16 h; [0520] To a solution of compound 51 (30 g, 0.15 mol) in DCM (300 mL) was added Et3N (64 mL, 0.46mo1), DMAP (5.6g, 0.046 mol), and then Boc2O (50 g, 0.23 mol) in portions at 0°C. After addition, the reaction mixture was stirred at room temperature for l6hrs. The mixture was diluted with DCM (200 mL) and washed with water and brine, dried over anhydrous Na2504, filtered and concentrated to dryness. The residue was purified by column chromatography on silica gel (eluted with Petroleum ether: Ethyl acetate = 50: 1) to give compound S2 (44 g, 97 percent yield) as a white solid. LC/MS (ESI) m/z: 240 (M-56+H).
97% With dmap; triethylamine In dichloromethane at 20℃; for 16 h; A mixture of 5-bromo-lH-indole (10.0 g, 51.0 mmol), Boc20 (16.7 g, 76.5 mmol), TEA (14.2 mL, 102.0 mmol) and DMAP (622 mg, 5.1 mmol) in DCM (150 mL) was stirred at room temperature for 16hrs. The mixture was evaporated under reduced pressure and the residue was purified by chromatography on silica gel (PE: EtOAc=50: l) to give the title compound (14.6 g, 97.0 percent yield) as white solid.
97% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 16 h; Inert atmosphere [0572] To a solution of compound 116 (30 g, 0.15 mol) in DCM (300 mL) was added Et3N (64 mL, 0.46mol), DMAP (5.6 g, 0.046 mol), then Boc2O (50 g, 0.23 mol) was added in portions at 0 oC. After addition, the reaction was stirred at room temperature for 16 hrs. The mixture was diluted with DCM (200 mL) and washed with water and brine, dried over anhydrous Na2SO4, filtered and concentrated to dryness. The residue was purified by column chromatography on silica gel (eluted with Petroleum ether: Ethyl acetate = 50: 1) to give the title compound (44 g, 97 percent yield) as white solid. LC/MS (ESI) m/z: 240 (M-56+H)+.
97% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 16 h; To a solution of compound S1 (30 g, 0.15 mol) in DCM (300 mL) at 0° C. was added Et3N (64 mL, 0.46 mol), DMAP (5.6 g, 0.046 mol). This was followed by addition of Boc2O (50 g, 0.23 mol) in portions. The reaction mixture was stirred at room temperature for 16 hrs. The mixture was diluted with DCM (200 mL) and washed with water and brine, dried over anhydrous Na2SO4, filtered and concentrated to dryness. The residue was purified by column chromatography on silica gel (eluted with petroleum ether: ethyl acetate=50:1) to give the title compound (44 g, 97percent yield) as white solid. LC/MS (ESI) m/z: 240 (M-56+H)+.
97% With dmap; triethylamine In dichloromethane at 0 - 20℃; for 16 h; To a solution of Scheme 6-7 compound 51 (30 g, 0.15 mol) in DCM (300 mL) was added Et3N (64 mL, 0.46mo1), DMAP (5.6 g, 0.046 mol), then Boc2O (50 g, 0.23 mol) was added in portions at 0 °C. After the addition was complete, the reaction was stirred at room temperature for 16 h. The mixture was diluted with DCM (200 mL), washed with water and brine, dried over anhydrous Na2504, filtered and concentrated to dryness. The residue was purified by column chromatography on silica gel (eluted with petroleum ether: ethyl acetate = 50: 1) to afford Scheme 6-7 compound S2 (44 g, 97 percent yield) as a white solid. LC/MS (ESI) m/z: 240 (M-56+H)t
86% With dmap In tetrahydrofuran at 20℃; for 16 h; Preparation of ferf-butyl 5-bromo-1H-indole-1-carboxylate Boc-anhydride (12.8 g, 58.65 mmol) was added to a stirred solution of 5-bromo-I H- indote (5.0 g, 25.50 mmol) in THF (100 mL) at room temperature. DMAP (1 ,24 g: 10.20 mmol) was added portionwise. The reaction mass was stirred at room temperature for 16 hours. After complete consumption of the starting material, THF was evaporated under vacuum. The residue was dissolved in EtOAc, washed with water folfowed by brine solution and dried over anhydrous Na2SO The organic layer was concentrated under reduced pressure to afford the crude product. The crude compel was purified on 100-200 mesh silica-gel eluting with 10percent EtOAc in petroleum ether to obtain an white solid (6.5 g, 86percent). 1H NMPv (400 MHz, CDCI3): δ 8.02 (br d, J - 8.4 Hz, 1 H), 7.69 (d, J - 2.0 Hz, 1 H), 7.58 (d, J = 4.0 Hz, 1 H), 7.39 (dd, J = 8.8 Hz, 2.0 Hz, 1 H), 6.50 (d, J = 3.6 Hz, 1 H), 1.67 (s, 9H). LCMS: m/z 297.0 [M+H]+.
23% With triethylamine In dichloromethane at 20℃; Heating / reflux (BoC)2O (23.35 g, 107.11 mmol) was added to a solution of 5-bromo-lH-indole (20 g, 102.04 mmol) in dichloromethane (120 mL). Et3N (10.302 g, 102.00 mmol) was then added, and the resulting solution was stirred at room temperature overnight, then for 6 hours at reflux temperature. The residue was purified by column chromatography using petroleum ether solvent to afford 7.21 g (23percent) of tert- butyl 5-bromo-lH-indole-l -carboxylate as a white solid.
27 g With dmap In dichloromethane at 0 - 20℃; for 16 h; 1 ,1 -Dimethylethyl 5-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 H-indole-1 - carboxylate(a) 1 ,1 -Dimethylethyl 5-bromo-1 H-indole-1 -carboxylate5-Bromoindole (20 g) and DMAP (1 g) were dissolved in DCM (200 ml.) and cooled to 0 °C. To this was added di-t-butyl dicarbonate (29 g) in portions. The reaction was allowed to warm to room temperature and was stirred at RT for 16 hrs. The reaction mixture was diluted with water and the organic layer was separated. The aqueous layer was extracted once with DCM and the combined organic layers were dried and evaporated to dryness. The crude product was purified by flash chromatography on silica to afford 27 g of the titled compound.

Reference: [1] Patent: EP1731505, 2006, A1, . Location in patent: Page/Page column 29-30
[2] Journal of the American Chemical Society, [3] Journal of the American Chemical Society, 2009, vol. 131, p. 1662 - 1663
[4] Patent: WO2010/59943, 2010, A2, . Location in patent: Page/Page column 36
[5] Synthesis, 2009, # 21, p. 3617 - 3632
[6] Patent: WO2017/35360, 2017, A1, . Location in patent: Paragraph 0520
[7] Patent: WO2017/35349, 2017, A1, . Location in patent: Paragraph 0638
[8] Patent: WO2017/35357, 2017, A1, . Location in patent: Paragraph 0461; 0572
[9] Patent: WO2017/35353, 2017, A1, . Location in patent: Paragraph 0710
[10] Patent: WO2017/35417, 2017, A1, . Location in patent: Paragraph 0630; 0652
[11] Angewandte Chemie, International Edition, 2009, vol. 48, # 23, p. 4235 - 4238
[12] Tetrahedron, 2009, vol. 65, # 34, p. 6877 - 6881
[13] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 7, p. 2156 - 2167
[14] Tetrahedron, 2000, vol. 56, # 43, p. 8473 - 8480
[15] Journal of the American Chemical Society, 2017, vol. 139, # 14, p. 5003 - 5006
[16] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
[17] Patent: WO2015/74123, 2015, A1, . Location in patent: Page/Page column 64
[18] Synthesis, 2008, # 5, p. 707 - 710
[19] Chemical Communications, 2012, vol. 48, # 26, p. 3239 - 3241
[20] Heterocycles, 2018, vol. 96, # 6, p. 1067 - 1074
[21] Synlett, 2008, # 2, p. 294 - 296
[22] Patent: WO2007/98418, 2007, A1, . Location in patent: Page/Page column 98
[23] Journal of Organic Chemistry, 2002, vol. 67, # 21, p. 7551 - 7552
[24] Patent: WO2013/28445, 2013, A1, . Location in patent: Page/Page column 56
[25] Journal of Medicinal Chemistry, 2013, vol. 56, # 17, p. 7060 - 7072
[26] Current Medicinal Chemistry, 2014, vol. 21, # 14, p. 1654 - 1666
[27] Marine Drugs, 2015, vol. 13, # 1, p. 460 - 492
[28] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 2, p. 131 - 136
  • 50
  • [ 10075-50-0 ]
  • [ 51300-90-4 ]
  • [ 182344-70-3 ]
Reference: [1] Marine Drugs, 2016, vol. 14, # 12,
  • 51
  • [ 10075-50-0 ]
  • [ 400071-95-6 ]
Reference: [1] European Journal of Medicinal Chemistry, 2001, vol. 36, # 6, p. 545 - 553
[2] Patent: EP2548864, 2013, A1,
[3] Patent: WO2013/14102, 2013, A1,
[4] Tetrahedron, 2016, vol. 72, # 5, p. 734 - 745
  • 52
  • [ 10075-50-0 ]
  • [ 325800-39-3 ]
Reference: [1] Chemical Papers, 2016, vol. 70, # 5, p. 635 - 648
  • 53
  • [ 10075-50-0 ]
  • [ 74-88-4 ]
  • [ 125872-95-9 ]
Reference: [1] Patent: WO2005/100301, 2005, A1, . Location in patent: Page/Page column 70
  • 54
  • [ 10075-50-0 ]
  • [ 475102-13-7 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 21, p. 7551 - 7552
  • 55
  • [ 10075-50-0 ]
  • [ 61350-62-7 ]
  • [ 143322-56-9 ]
YieldReaction ConditionsOperation in experiment
83%
Stage #1: With aluminum (III) chloride In dichloromethane at 0 - 5℃; for 1 h;
Stage #2: at 0 - 5℃; for 6 h;
5-bromoindole (15.7 g, 80.4 mmol), dichloromethane (140 mL) was added to a 500 ml four-necked flask,The ice bath was cooled to 0 ° C and the aluminum trichloride solid (16.1 g, 120.6 mmol) was slowly added in portions,The internal temperature control in the 0 ~ 5 , stirring reaction 1h, 0 ~ 5 conditions,A solution of N-benzyloxycarbonyl prolyloyl chloride in Example 1 in dichloromethane was added dropwise,The reaction solution was stirred at 0-5 ° C for 6 h. Ice bath, 90mL saturated ammonium chloride solution slowly drip,First filter, the filtrate layer, the organic phase in turn with saturated sodium bicarbonate, saturated salt water washing,After concentration under reduced pressure, the crude product was purified by recrystallization from a mixed solvent of ethyl acetate and n-heptane (1: 1 by volume), vacuum dried at 60 ° C for 8 hours,(R) -3- (N-benzyloxycarbonylpyrrolidin-2-ylcarbonyl) -5-bromo-lH-indole (14.2 g) as a white solid,The yield was 83percent and the HPLC purity was 99.2percent.
Reference: [1] Patent: CN104230895, 2017, B, . Location in patent: Paragraph 0031; 0032; 0033; 0034; 0035; 0036-0044
[2] Medicinal Chemistry Research, 1999, vol. 9, # 9, p. 668 - 674
[3] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3419 - 3421
[4] Patent: US2008/319205, 2008, A1, . Location in patent: Page/Page column 7
[5] Patent: US2011/166364, 2011, A1, . Location in patent: Page/Page column 4
[6] Patent: US2012/71669, 2012, A1, . Location in patent: Page/Page column 12
  • 56
  • [ 10075-50-0 ]
  • [ 144-55-8 ]
  • [ 61350-62-7 ]
  • [ 143322-56-9 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With tert-butylmagnesium chloride In diethyl ether at 0 - 20℃; for 0.75 h;
N-Benzyloxycarbonyl-R-proline acid chloride from the above reaction was dissolved in anhydrous diethyl ether (30 mL) and added at 0 °C to a solution of 5-bromoindole (2.9 g, 15.0 mmol) and t-butylmagnesium chloride (2M solution in diethyl ether, 8.3 mL, 16.5 mmol) in anhydrous diethyl ether (30 mL).
The resulting mixture was stirred at room temperature under argon for 45 minutes and then ethyl acetate (150 mL) and saturated sodium bicarbonate (30 mL) were added.
The organic layer was dried and evaporated under reduced pressure to provide a yellow oil.
The title compound was crystallized using hexane/ethyl acetate (9:1) to provide a white solid (3.07 g, 72percent).
mp 95-96 °C.
Reference: [1] Patent: EP944595, 2003, B1, . Location in patent: Page/Page column 13
  • 57
  • [ 10075-50-0 ]
  • [ 676-58-4 ]
  • [ 61350-62-7 ]
  • [ 143322-56-9 ]
Reference: [1] Patent: WO2010/121673, 2010, A1, . Location in patent: Page/Page column 16-17
  • 58
  • [ 10075-50-0 ]
  • [ 79-37-8 ]
  • [ 925-90-6 ]
  • [ 61350-62-7 ]
  • [ 6404-31-5 ]
  • [ 143322-56-9 ]
Reference: [1] Patent: US5545644, 1996, A,
[2] Patent: US5559129, 1996, A,
[3] Patent: US5559246, 1996, A,
[4] Patent: US5578612, 1996, A,
[5] Patent: US5607951, 1997, A,
  • 59
  • [ 10075-50-0 ]
  • [ 925-90-6 ]
  • [ 144-55-8 ]
  • [ 61350-62-7 ]
  • [ 143322-56-9 ]
Reference: [1] Patent: US5545644, 1996, A,
[2] Patent: US5559129, 1996, A,
[3] Patent: US5559246, 1996, A,
[4] Patent: US5578612, 1996, A,
[5] Patent: US5607951, 1997, A,
[6] Patent: US5639779, 1997, A,
  • 60
  • [ 10075-50-0 ]
  • [ 73183-34-3 ]
  • [ 269410-24-4 ]
YieldReaction ConditionsOperation in experiment
90% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane for 8 h; Inert atmosphere; Reflux Into a 500 ml single-mouth flask, successively add 5-bromoindole (20.00g, 0 . 1mol), bis(pinacolato)diboron (51.80g, 0 . 2mmol), potassium acetate (22.80g, 0 . 2mol), [ 1,1 '-bis (diphenylphosphino) ferrocene] palladium dichloride (1.50g), and 350 ml dioxane. Under the protection of nitrogen, reflux for 8h. Cooling latter turns on lathe steams removing dioxane, with 200 ml distilled water dichloromethane is used for extraction after washing 3 times. Re-crystallization with methanol-methylene chloride to obtain the product 21.8g, the yield is 90percent.
83% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 100℃; for 5.33333 h; Inert atmosphere 5-Bromoindole (2 g, 10.2 nmol) and Bis(pinacolato)diboron (4 g, 19.2 mmol) was dissolved in 1,4-dioxane and then PdCl2(dppf) (524 mg, 0.72 mmol) and potassium acetate(3 g, 30.6 mmol) were added. The suspension was bubbled with nitrogen for 20 min and then stirred at 100 °C for 5 h. After the mixture was cooled at room temperature and quenched with water. Then the solution was extracted with ethyl acetate (20 mL × 3), and the combined organic layer was washed by saturated sodium chloride solution for three times, dried over anhydrous Na2SO4 and concentrated under reduced pressure. Finally, the residue was puried by silica gel chromatography to get white solid a. HPLC purity: 96.7percent. Yield: 83percent. 13C NMR (100MHz, DMSO-d6): δ 138.34(1C, C-8), 128.32(1C, C-3), 127.77(1C, C-5), 127.29(1C, C-1), 126.94(1C, C-4), 123.79(1C, C-6), 111.27(1C, C-7), 102.03(1C, C-2), 83.42(2C, - C-O), 25.06(4C, -CH3). HR-MS (ESI) calcd for C14H18BNO2 [M+ Na] +: 266.1323; found: 266.1393.
75% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Under a nitrogen flow 5-bromo-1H-indole (100.0 g, 510.1 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi (1,3 ,2-dioxaborolane) (142.5 g, 561.1 mmol), Pd(dppf)Cl2 (44.7 g, 51.0 mmol), KOAc (144.1 g, 1.52mol) and 1,4-dioxane (2500 ml) and the mixture was stirred at 130 °C for 12 hours. After the reaction was terminated by the removal of water and then extracted with ethyl acetate MgSO4, and purified by column chromatography. (Hexane: EA = 8: 1 (v / v)) to give 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (93.0 g, with a yield of 75percent).
72% With [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II); potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen flow 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3 ,2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl2 (5.2 g, 5 mol), KOAc (37.55g, 0.383mol) and 1,4-dioxane (500 ml) the mixture, and then the 130 in it was stirred for 12 hours.After the reaction was completed, the removal of water in our MgSO4 and then extracted with ethyl acetate, column chromatography (Hexane: ethyl acetate (EA) = 10: 1 (v / v)) to give 5- (4,4,5 a , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole (22.32 g, a yield of 72percent).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen stream, 5-bromo-1H-indole (25g, 0.128mol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane)(48.58g, 0.191mol), Pd (dppf) Cl2 (5.2g, 5mol), KOAc (37.55g, 0.383mol), and 1,4-dioxane (500ml) mixed, and the mixture was stirred for 12 hours at 130°C .After completion of the reaction, and extracted with ethyl acetate, water was removed by MgSO4, column chromatography (hexane: EA = 10: 1 (v / v)) purified to at 5- (4,4,5,5-tetra to give methyl 1,3,2-dioxaborolan-2-yl)-lH-indole (22.32g, 72percent yield).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen flow 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3 ,2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl2 (5.2 g,5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) and the mixture 130 ° Cin was stirred for 12 hours. After the reaction was terminated by the removal of water and then extracted with ethylacetate and MgSO4, purified by column chromatography (Hexane: EA = 10: 1 (v / v))purified 5- (4,4,5,5-tetramethyl- by a 1,3,2-dioxaborolan-2-yl) -1H-indole (22.32g, a yield of 72percent).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen flow 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) and the mixture at 130°C , It was stirred for 12 hours. After the reaction was terminated by the removal of water and then extracted with ethyl acetate and MgSO4, purified by column chromatography (Hexane: EA = 10: 1 (v / v)) 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22.32 g, a yield of 72percent).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen stream, 5-bromo -1H- indole (25g, 0.128mol), 4,4,4 ', 4', 5,5,5 ', 5'- octamethyl-2,2'-bi (1, 3,2-dioxaborolane) (48.58g, 0.191mol), Pd (dppf) Cl2 (5.2g, 5molpercent), KOAc (37.55g, 0.383mol), and 1,4-dioxane (500ml) It was mixed, and the mixture was stirred for 12 hours at 130°C .After completion of the reaction, and extracted with ethyl acetate, water was removed by MgSO4, column chromatography (hexane:: EA = 10 1 (v / v)), 5- (4,4,5,5- tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole was obtained.(22.32g, 72percent yield).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under the nitrogen air 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) were mixed, then it was stirred at 130 °C for 12 hours. After reaction being terminated, then ethyl acetate extraction of MgSO 4 for removing moisture to, column chromatography ( reaction is concluded Hexane: it was refined to the EA = 10:1 (v/v)) for purifying the 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22.32 g, yield 72percent) were obtained.
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under a nitrogen flow 5-bromo-1H-indole ( 25 g, 0.128 mol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd (dppf) Cl 2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol)and 1,4-dioxane (500 ml) and the mixture 130 °C in was stirred for 12 hours. The reaction was terminated, and then extracted with ethyl acetate MgSO4to remove water to and purified by column chromatography to give 5- (4,4,5,5-tetramethyl-1,3,2- dioxaborolan-2-yl) -1H-indole to obtain a (22.32 g, 72percent yield).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere synthesis of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H- indole Under a nitrogen stream, 5-bromo--1H- indole (25g, 0.128mol) 4,4,4 ', 4', 5,5,5 ', 5'- octamethyl-2,2'-bi (1,3 , 2-dioxaborolane) (mixed 48.58g, 0.191mol), Pd (dppf) Cl2 (5.2g, 5mol), KOAc (37.55g, 0.383mol), and 1,4-dioxane (500ml) after, the mixture was stirred for 12 hours at 130 . After completion of the reaction, and extracted with ethyl acetate, water was removed by MgSO4, column chromatography [hexane: ethyl acetate (EA) = 10: 1 (v / v)] in purified 5- (4,4,5 to give 5-tetramethyl-1,3,2-dioxaborolan-2-yl)-lH-indole (22.32g, 72percent yield).
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; Inert atmosphere Under nitrogen, 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 0.05 mol), and potassium acetate (KOAc) (37.55 g, 0.383 mol) were dissolved in a round-bottomed flask filled with 1,4-dioxane (500 ml). The mixed reactants were stirred for 12 h at 130 °C. After the reaction was terminated, the mixture was extracted with ethyl acetate three times. The organic layer was separated and the moisture was removed by drying over MgSO4. After removing the solvent by evaporation, the crude product was purified by column chromatography with an ethyl acetate and n-hexane (1:10) eluent. Yield 72percent (22.32 g), 1H NMR (400 MHz, DMSO): δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 (s, 1H). MS (APCI) m/z 244.11 [(M + H)+].
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; 5-bromo-1H-indole 25 g (128 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane ) 48.58 g (0.191 mmol), Pd (dppf) Cl25.2 g (6.4 mmol), KOAc 37.55 g (383 mmol) and dioxane 500 mL and 130 the mixture heated at reflux 12 hours.Allowed to cool to room temperature and quench the reaction with 500 mL aqueous solution of ammonium chloride to the reaction mixture.Extract the mixture with EA 500 mL, and washed with distilled water.The resulting organic layer was dried over anhydrous MgSO4,and evaporated under reduced pressure to give the desired compound 22.32 g (72percent yield) was purified by a silica gel column chromatography.
72% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 130℃; for 12 h; (25 g, 0.128 mol), 4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3, Dioxane (500 ml) were mixed and heated at 130 for 12 hours at 130 . The resulting mixture was stirred at 130 for 2 hours to obtain a mixture of d- (2-dioxaborolane) (48.58 g, 0.191 mol), d After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4, and the residue was purified by column chromatography to obtain 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 -yl) -1H-indole (22.32 g, yield 72percent).
40% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl-formamide at 130℃; for 12 h; Inert atmosphere Under a nitrogen stream, 5-bromo-1H-indole (25g, 0.128mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi-(1,3,2-dioxaborolane) (48.58g, 0.191mol), Pd(dppf)Cl2 (5.2g, 5mol), KOAc (37.55g, 0.383mol) and a mixture of DMF (500ml), 12 hours with stirring at 130 °C. After completion of the reaction, and extracted with ethyl acetate, to remove water with MgSO4, is purified by Karamukuro Matogurafi (Hexane: EA = 10: 1 (v / v)) was obtained 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)-1H-indole (12.43g, 40percent yield).
40% With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; potassium acetate In N,N-dimethyl-formamide at 130℃; for 12 h; Inert atmosphere 5-bromo-1H-indole (25 g, 0.128 mol) was added under a nitrogen stream, 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane)(48.58 g, 0.191 mol), Pd (dppf) Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) andWere mixed DMF (500 ml) And the mixture was stirred at 130 DEG C for 12 hours.After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO4,Purification by column chromatography (Hexane: EA = 10: 1 (v / v)) gave5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole(12.43 g, yield 40percent).
280 mg With tris-(dibenzylideneacetone)dipalladium(0); potassium acetate; XPhos In 1,4-dioxane at 115℃; for 18 h; Inert atmosphere To a solution of 5-bromo-1H-indole (200 mg, 1.02 mmol) in dioxane (10 mL) were added bis (pinacolato) diboron (309.8 mg, 1.22 mmol) , potassium acetate (300 mg, 3.06 mmol) , X-Phos (48.5 mg, 0.10 mmol) and tris (dibenzylideneacetone) dipalladium (46.7 mg, 0.05 mmol) . The mixture was stirred under N2at 115 for 18 h. After the reaction was completed, the reaction mixture was filtered through a Celite pad. The filtrate was concentrated in vacuo. The residue was purified by silica gel column chromatography eluted with PE/EtOAc (v/v) 8/1) to give a yellow solid product (280 mg) .[0781]MS (ESI, pos. ion) m/z: 244.2 [M+1]+.
3.65 g With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In toluene for 16 h; Reflux Bromide 1-6-a (3.92 g, 20 mmol), boronic acid pinacol ester (6.22 g, 24 mmol),1,1'-bis(diphenylphosphino)-ferrocene-palladium(II)dichloride dichloromethane complex (0.49 g, 0.6 mmol), potassium acetate (5.90 g, 0 mmol) and 79 ml of toluene The reaction was refluxed for 16 hours, cooled, added with 26 ml of water, stirred for 30 minutes, the organic phase was separated, filtered through a short celite bed, and then the organic solvent was evaporated, and the crude product was recrystallized from heptane / toluene; Under argon atmosphere,The obtained solid (3.65 g, 15 mmol), bromobenzene (2.06 g, 14.3 mmol), tetrakis(triphenylphosphine)palladium (0.35 g, 0.3 mmol), toluene (43 ml), aqueous sodium carbonate (2M, 21 ml) The mixture was placed in a flask, and the mixture was refluxed for 8 hours, cooled to room temperature, and extracted with toluene. The organic phase was washed with saturated brine, and then dried, and then purified by column chromatography to afford compound 1-6 3.59 g.

Reference: [1] Patent: CN105601612, 2016, A, . Location in patent: Paragraph 0051; 0052; 0053
[2] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
[3] Organic Letters, 2012, vol. 14, # 2, p. 600 - 603
[4] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4150 - 4155
[5] Patent: KR101603387, 2016, B1, . Location in patent: Paragraph 0084-0088; 0143-0146
[6] Patent: KR101571589, 2015, B1, . Location in patent: Paragraph 0172-0176
[7] Patent: JP2015/528445, 2015, A, . Location in patent: Paragraph 0047; 0048
[8] Patent: KR101548040, 2015, B1, . Location in patent: Paragraph 0094-0098
[9] Patent: KR2015/88007, 2015, A, . Location in patent: Paragraph 0095; 0096; 0097
[10] Patent: JP2015/527347, 2015, A, . Location in patent: Paragraph 0052; 0053; 0069; 0074
[11] Patent: KR101577099, 2015, B1, . Location in patent: Paragraph 0168-0172
[12] Patent: KR2015/38811, 2015, A, . Location in patent: Paragraph 0140-0143
[13] Patent: JP2015/530991, 2015, A, . Location in patent: Paragraph 0056-0057
[14] Dyes and Pigments, 2017, vol. 136, p. 529 - 534
[15] Patent: KR101571592, 2015, B1, . Location in patent: Paragraph 0130-0134
[16] Patent: KR101599586, 2016, B1, . Location in patent: Paragraph 0110-0113
[17] Synlett, 2003, # 8, p. 1204 - 1206
[18] Journal of the American Chemical Society, 2017, vol. 139, # 24, p. 8267 - 8276
[19] Patent: JP2016/40292, 2016, A, . Location in patent: Paragraph 0038-0040
[20] Patent: KR101879905, 2018, B1, . Location in patent: Paragraph 0185-0189
[21] European Journal of Medicinal Chemistry, 2009, vol. 44, # 5, p. 1900 - 1912
[22] ChemCatChem, 2014, vol. 6, # 5, p. 1340 - 1348
[23] Patent: WO2016/615, 2016, A1, . Location in patent: Paragraph 00482
[24] Patent: CN104817489, 2017, B, . Location in patent: Paragraph 0056-0057
[25] Patent: CN108530336, 2018, A, . Location in patent: Paragraph 0077; 0079; 0083
  • 61
  • [ 10075-50-0 ]
  • [ 25015-63-8 ]
  • [ 269410-24-4 ]
Reference: [1] Patent: US6680401, 2004, B1, . Location in patent: Page column 68
  • 62
  • [ 10075-50-0 ]
  • [ 269410-24-4 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 20, p. 6812 - 6820
[2] Heterocycles, 2010, vol. 80, # 2, p. 1267 - 1274
  • 63
  • [ 10075-50-0 ]
  • [ 17274-68-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 3, p. 727 - 729
[2] Patent: EP944595, 2003, B1,
  • 64
  • [ 10075-50-0 ]
  • [ 393105-53-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 14, p. 3491 - 3494
  • 65
  • [ 10075-50-0 ]
  • [ 837392-62-8 ]
Reference: [1] Helvetica Chimica Acta, 2006, vol. 89, # 5, p. 936 - 946
[2] Patent: WO2016/180537, 2016, A1,
  • 66
  • [ 10075-50-0 ]
  • [ 201227-38-5 ]
YieldReaction ConditionsOperation in experiment
76% With hydrogenchloride; sodium nitrite In water; acetone at -10 - 20℃; for 3 h; A solution of NaNO2 (110.4 g, 1.6 mol, 8 eq) in water (200 mL) was added dropwise to a solution of 5-bromoindole (XI) (39.2 g, 0.2 mol, 1 eq) in acetone (1000 mL) stirred at −10→0° C., while adding NaNO2 the solution temperature was maintained below 20° C. An aqueous 2N HCl solution (480 mL) was added slowly to the solution with vigorously stirring while keeping the internal temperature between 0 and 20° C. The solution was further stirred at 20° C. for 3 h after the addition. The solution was concentrated under reduced pressure to remove acetone while keeping the temperature below 35° C. The solid was collected by filtration and transferred to a flask. Cold (−10° C.) DCM (200 mL) was added and stirred for 30 min at −5° C., the solids were filtered and dried under vacuum at 40° C. to get 5-bromo-1H-indazole-3-carbaldehyde (XII) (34.0 g, 151 mmol, 76percent yield) as a brown solid. ESIMS found for C8H5BrN2O m/z 225 (M+H).
Reference: [1] Patent: US2016/75701, 2016, A1, . Location in patent: Paragraph 0798; 0799
[2] Patent: US2006/4000, 2006, A1, . Location in patent: Page/Page column 19
  • 67
  • [ 10075-50-0 ]
  • [ 75-09-2 ]
  • [ 201227-38-5 ]
YieldReaction ConditionsOperation in experiment
76%
Stage #1: With water; sodium nitrite In acetone at -10 - 20℃;
Stage #2: With hydrogenchloride In water at 20℃; for 3 h;
Stage #3: at -5℃; for 0.5 h;
Step 1
A solution of NaNO2 (110.4 g, 1.6 mol, 8 eq) in water (200 mL) was added dropwise to a solution of 5-bromoindole (I) (39.2 g, 0.2 mol, 1 eq) in acetone (1000 mL) stirred at -10→0° C., while adding NaNO2 the solution temperature was maintained below 20° C.
An aqueous 2N HCl solution (480 mL) was added slowly to the solution with vigorously stirring while keeping the internal temperature between 0 and 20° C.
The solution was further stirred at 20° C. for 3 h after the addition.
The solution was concentrated under reduced pressure to remove acetone while keeping the temperature below 35° C.
The solid was collected by filtration and transferred to a flask.
Cold (-10° C.) DCM (200 mL) was added and stirred for 30 min at -5° C., the solids were filtered and dried under vacuum at 40° C. to get 5-bromo-1H-indazole-3-carbaldehyde (II) (34.0 g, 151 mmol, 76percent yield) as a brown solid. ESIMS found for C8H5BrN2O m/z 225 (M+H).
Reference: [1] Patent: US2014/194441, 2014, A1, . Location in patent: Paragraph 0396
  • 68
  • [ 10075-50-0 ]
  • [ 201227-38-5 ]
  • [ 585-76-2 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 24, p. 13121 - 13128
  • 69
  • [ 10075-50-0 ]
  • [ 152213-63-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 10, p. 2101 - 2112
  • 70
  • [ 10075-50-0 ]
  • [ 261732-38-1 ]
Reference: [1] Patent: US2012/329649, 2012, A1,
[2] Patent: US2014/171314, 2014, A1,
[3] Patent: WO2014/100163, 2014, A1,
[4] Patent: US2014/171308, 2014, A1,
[5] Patent: WO2014/100206, 2014, A1,
[6] Patent: US2014/171312, 2014, A1,
[7] Patent: US9211280, 2015, B2,
  • 71
  • [ 67-56-1 ]
  • [ 10075-50-0 ]
  • [ 76-02-8 ]
  • [ 773873-77-1 ]
Reference: [1] Journal of the American Chemical Society, 2008, vol. 130, # 48, p. 16162 - 16163
[2] European Journal of Medicinal Chemistry, 2013, vol. 64, p. 498 - 511
[3] Medicinal Chemistry Research, 2013, vol. 22, # 9, p. 4492 - 4504
  • 72
  • [ 10075-50-0 ]
  • [ 773873-77-1 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 19, p. 2376 - 2385
[2] Organic Letters, 2016, vol. 18, # 24, p. 6504 - 6507
[3] Chemical Papers, 2018, vol. 72, # 6, p. 1369 - 1378
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 10075-50-0 ]

Vilazodone Intermediates

Chemical Structure| 183288-46-2

[ 183288-46-2 ]

5-(Piperazin-1-yl)benzofuran-2-carboxamide

Related Functional Groups of
[ 10075-50-0 ]

Bromides

Chemical Structure| 1075-34-9

[ 1075-34-9 ]

5-Bromo-2-methylindole

Similarity: 0.98

Chemical Structure| 52415-29-9

[ 52415-29-9 ]

6-Bromoindole

Similarity: 0.98

Chemical Structure| 1000343-13-4

[ 1000343-13-4 ]

5-Bromo-6-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 854923-38-9

[ 854923-38-9 ]

5,6-Dibromo-1H-indole

Similarity: 0.96

Chemical Structure| 10075-48-6

[ 10075-48-6 ]

5-Bromo-3-methyl-1H-indole

Similarity: 0.96

Related Parent Nucleus of
[ 10075-50-0 ]

Indoles

Chemical Structure| 1075-34-9

[ 1075-34-9 ]

5-Bromo-2-methylindole

Similarity: 0.98

Chemical Structure| 52415-29-9

[ 52415-29-9 ]

6-Bromoindole

Similarity: 0.98

Chemical Structure| 1000343-13-4

[ 1000343-13-4 ]

5-Bromo-6-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 854923-38-9

[ 854923-38-9 ]

5,6-Dibromo-1H-indole

Similarity: 0.96

Chemical Structure| 10075-48-6

[ 10075-48-6 ]

5-Bromo-3-methyl-1H-indole

Similarity: 0.96